Avery

Name

Avery

Legal name

Avery Biomedical Devices, Inc.

Website

https://averybiomedical.com

Company type

Private

Founded year

1970

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Implantable Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Cardiac Rhythm Management (Pacemakers, ICDs, CRT) (HLAHAFAC)

akta.pro secondary industries

Sleep Apnea Therapy Devices (CPAP/APAP/BiPAP/ASV) (HLAHAGAA), Ventilators & Mechanical Ventilation Systems (ICU/Transport/Home) (HLAHAGAC)

Keywords

• Diaphragm pacemaker system
• Phrenic nerve stimulator
• Implantable medical devices
• Ventilatory support devices
• Neuromodulation implants

Headquarters

HQ city

Commack

HQ country

United States

HQ region

North America

Offices7 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

1. Medical Device Sales: Sale of the Avery Diaphragm Pacing System including implanted receivers, electrodes, external Spirit transmitter, and antennas. The system has a 10-year service life for Spirit transmitter and implanted receivers. Electrodes last the lifetime of the patient.
2. Technical Support Services: Technical support provided at no additional cost. On-site support provided during each surgery. Virtual and on-site in-service training for hospital staff.
3. Disposable Supplies: Annual replacement of external antennas and batteries. Less than $1,500 per year for disposable supplies.
4. Insurance Reimbursement: Equipment is reimbursed by Medicare and many private and government insurance plans around the world. The company coordinates with insurance carriers for approval.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels7 records

Core offering

Avery Biomedical Devices manufactures the Avery Diaphragm Pacing System, an implanted phrenic nerve stimulator consisting of surgically implanted receivers and electrodes paired with an external Spirit transmitter and antennas. The system delivers radiofrequency energy through intact skin to power implanted receivers, which stimulate the phrenic nerves to cause diaphragm contraction, providing chronic ventilatory support as an alternative to mechanical ventilation. The only diaphragm pacemaker with full FDA PMA approval and CE marking privileges for both adult and pediatric use.

Product overview

Avery Biomedical Devices offers a single unified product—the Avery Diaphragm Pacing System—which is an implanted phrenic nerve stimulator for providing chronic ventilatory support. The system consists of the Spirit Transmitter (external component worn by the patient) and surgically implanted receivers and electrodes. The device stimulates the phrenic nerves to cause diaphragm contraction, enabling natural breathing without mechanical ventilation. It is the only diaphragm pacemaker with full FDA PMA approval and CE marking privileges for both adult and pediatric patients with conditions including high spinal cord injury, central hypoventilation syndrome (CCHS), central sleep apnea, and diaphragm paralysis.

Differentiator

Problem solved

Functional benefit

Brands

• Avery Diaphragm Pacing System: Implanted phrenic nerve stimulator system consisting of surgically implanted receivers and electrodes and external transmitter and antennas for diaphragm pacing
• Spirit Transmitter

Products and services

• Avery Diaphragm Pacing System Implanted phrenic nerve stimulator (diaphragm pacemaker) system consisting of surgically implanted receivers and electrodes and an external transmitter with antennas. Provides chronic ventilatory support as an alternative to mechanical ventilation for patients with high spinal cord injury, CCHS, central sleep apnea, and diaphragm paralysis. Indicated for persons requiring chronic ventilatory support due to upper motor neuron respiratory muscle paralysis or central alveolar hypoventilation.
• Spirit Transmitter The external component of the Avery Diaphragm Pacing System that sends radiofrequency energy through intact skin to the implanted receivers. Worn with a belt or shoulder strap and powered by four AA alkaline batteries. Patients or caregivers can adjust amplitude and respiratory rate without special tools.

Quantifiable outcome

• Saves over $20,000 per year compared to mechanical ventilation ($1,500-$2,500/month vs. <$1,500/year for Avery)
• +4 more outcomes

Named customers14 records

Segments5 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature9 records

Partnerships

14 partnerships are on record, tiered core and minor.

• George Washington University HospitalcoreStrategic or Co-development Partner · 1 August 2018Major teaching hospital where Dr. Keith Mortman implanted Richard with the Avery Diaphragm Pacing System in August 2018.
• Dr. Mark E GinsburgcoreStrategic or Co-development Partner · 1 July 2014World-renowned Thoracic and Cardiovascular surgeon appointed to Avery's Board of Directors in July 2014. Has over 34 years of experience and has been implanting the Avery Diaphragm Pacing System since the late 1980s. Practices at NY Presbyterian Hospital and Good Samaritan Regional Medical Center.
• Dr. Don HeadleycoreStrategic or Co-development Partner · 1 January 2012Otolaryngologist (ENT) with almost 40 years of medical experience and over 20 years specifically with Avery Diaphragm Pacing Systems. Named Clinical Consultant to Avery Biomedical Devices in 2012. Affiliated with St. Joseph's Hospital and Medical Center in Phoenix, Arizona. Recognized by Healthgrades as a Healthgrades Choice Provider.
• CCHS NetworkcoreOthersPatient advocacy organization for Congenital Central Hypoventilation Syndrome families. CCHS Network logo appears on Avery's partner page indicating collaboration in patient education and awareness.
• Christopher and Dana Reeve FoundationcoreOthersNonprofit organization focused on spinal cord injury research and quality of life. Their logo appears on Avery's partner page indicating collaboration in patient resources.
• United Spinal AssociationcoreOthersOrganization dedicated to empowering people with spinal cord injuries and disorders. Logo appears on Avery's partner page indicating collaboration in patient education.
• Children's Hospital Los AngelescoreStrategic or Co-development PartnerLeading pediatric hospital that has created a DVD presentation on their experience using the Avery Diaphragm Pacing System in CCHS patients through a grant from the Christopher and Dana Reeve Foundation. Actively implants Avery systems in children.
• Mesothelioma Veterans CenterminorOthersResource center for veterans with mesothelioma. Logo appears on Avery's partner page indicating collaboration in veteran patient education.
• Amedtech SRLcoreChannel Partner/ Reseller/ DistributorExclusive representative for Avery Pacer in Argentina. Located at Olleros 2404 CP (1426), Buenos Aires, Argentina. Contact: Juan Santurian, Phone: (+54 11) 4777-9622.
• Bioingeniería SpAcoreChannel Partner/ Reseller/ DistributorExclusive representative for Avery Pacer in Chile. Located at Brasilera 0304, Punta Arenas, Chile. Contact: Carlos Fortune Cabello.
• Medihumana Colombia S.A.coreChannel Partner/ Reseller/ DistributorExclusive representative for Avery Pacer in Colombia. Located at Calle 90 # 19 A- 49 Oficina 706, Bogotá, Colombia. Contact: Línea en Bogotá: +57 (601) 611-4015.
• Lowenstein MedicalcoreChannel Partner/ Reseller/ DistributorExclusive representative for Avery Pacer in Israel. Contact: David Dagan, T: +972-8-9157877.
• ZAO Innotek MedicalcoreChannel Partner/ Reseller/ DistributorExclusive representative for Avery Pacer in Russia. Located at 1A, 4, Leninsky Prospect, 119049 Moscow, Russia. Contact: Edward Indilov, PhD, +7 (495) 215-18-68.
• Bridgeway Medical SystemscoreChannel Partner/ Reseller/ DistributorExclusive representative for Avery Pacer in United Arab Emirates. Located at 1st Floor, Al Ashram Building, Garhoud, Dubai. Contact: Riyas Rahman, Tel: +971 4282-2890.

Scale indicators8 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Respicardia (ZOLL): Makes the remede System, an implanted phrenic nerve stimulator for central sleep apnea. Direct competitor in the same phrenic nerve stimulation category, though remede is approved only for adult CSA, not the broader SCI/CCHS indications Avery serves.
• Synapse Biomedical: Direct competitor with the NeuRx Diaphragm Pacing System, the other commercially available diaphragm pacemaker. Uses percutaneous electrodes rather than Avery's fully implantable RF approach. Only FDA-approved for adults 18+, making pediatric Avery's stronghold.

Others

• Fisher & Paykel Healthcare: Global respiratory care equipment manufacturer specializing in humidification, CPAP, and nasal interfaces. An adjacent player in the broader respiratory care ecosystem where Avery's diaphragm pacemakers serve as an alternative to non-invasive ventilation.
• Philips Respironics: Major manufacturer of mechanical ventilators, CPAP, and hospital respiratory care equipment. Represents the broader mechanical ventilation incumbent that Avery's diaphragm pacemaker displaces. Comparable as a competitor for respiratory care budgets and clinician mindshare.
• ResMed: Global leader in CPAP/BiPAP and mechanical ventilation equipment. Avery's device is a direct alternative to mechanical ventilation, so ResMed is the incumbent therapy whose patients represent Avery's primary switch opportunity. Not a direct competitor, but the dominant alternative therapy.

Broad incumbents

• Boston Scientific: Major player in cardiac rhythm management, spinal cord stimulators, and deep brain stimulation. Represents a potential strategic acquirer with neuromodulation expertise that could enter phrenic nerve stimulation or absorb Avery's clinical footprint.
• Medtronic: Global leader in implantable pulse generators, pacemakers, and neuromodulation devices. Avery operates in an adjacent niche (phrenic nerve) that Medtronic could enter with its existing IPG and neurostim capabilities, posing an indirect competitive threat.
• Nevro: Spinal cord stimulation company using implanted pulse generators. Comparable as an implanted neurostim business model targeting chronic conditions, though Nevro focuses on chronic pain rather than respiratory indications.
• LivaNova: Implantable neuromodulation company with vagus nerve stimulation and other neurostim platforms. Comparable as a peer in the implanted neurostimulator business model and regulatory/commercial pathway, though addressing different therapeutic targets.
• Inspire Medical Systems: Market leader in hypoglossal nerve stimulation for obstructive sleep apnea. While targeting OSA rather than central hypoventilation, Inspire represents the broader implanted neurostim approach for sleep-disordered breathing and a strategic reference point for Avery's neurostim business model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/averybiomedical
• YouTubeyoutube.com/@AveryBiomedical
• Facebookfacebook.com/AveryBiomedical
• LinkedInlinkedin.com/company/avery-biomedical-devices-inc-
• Instagraminstagram.com/averybiomedical

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Avery